Palisade Bio shareholders approve increase in authorized shares to 300M and warrant issuance of up to 8.64M shares

PALISADE BIO, INC.

Authorized common stock increased from 280M to 300M shares via certificate of amendment filed Dec. 3, 2025.
Stockholders approved issuance of up to 8,637,810 common shares underlying warrants under July 23, 2025 inducement agreement.
Proposal passed with ~126.3M votes for; quorum of 85.53% of outstanding shares (148.96M) represented.
Warrant exercise required under Nasdaq Listing Rule 5635 because shares exceed 20% of pre-issuance outstanding.
Adjournment proposal also approved to allow further solicitation if needed.

item 5.03 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PALISADE BIO, INC.: Increased authorized shares of common stock from 280,000,000 to 300,000,000 (effective 2025-12-03).

Change: charter amendment
Effective: 2025-12-03

Exact text from the filing

On December 3, 2025, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Amendment") with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 280,000,000 shares to 300,000,000 shares.

View on SEC.gov

241 governance changes filed in the last 30 days. Browse all governance changes →

PALISADE BIO, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-026195

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.